FTSE 100
|
9 216,67
|
-11,44
|
-0,12 %
|
Analysen zu FTSE 100-Werten
| 21.02.24 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 21.02.24 | HSBC Holdings Neutral | UBS AG | |
| 21.02.24 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 20.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 20.02.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 19.02.24 | BAT Overweight | Barclays Capital | |
| 19.02.24 | Unilever Overweight | Barclays Capital | |
| 19.02.24 | AstraZeneca Sell | UBS AG | |
| 19.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.02.24 | Shell Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 16.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.02.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 15.02.24 | BAT Buy | Deutsche Bank AG | |
| 15.02.24 | RELX Buy | UBS AG | |
| 15.02.24 | Shell Outperform | RBC Capital Markets | |
| 15.02.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.02.24 | BP Buy | UBS AG | |
| 14.02.24 | Unilever Sell | UBS AG | |
| 14.02.24 | easyJet Buy | Deutsche Bank AG | |
| 13.02.24 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 13.02.24 | Unilever Halten | DZ BANK | |
| 13.02.24 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 13.02.24 | BAT Neutral | UBS AG | |
| 13.02.24 | Glencore Outperform | RBC Capital Markets | |
| 13.02.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 12.02.24 | AstraZeneca Halten | DZ BANK | |
| 12.02.24 | Unilever Market-Perform | Bernstein Research | |
| 12.02.24 | Reckitt Benckiser Outperform | Bernstein Research | |
| 12.02.24 | Diageo Sell | Deutsche Bank AG | |
| 12.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | BP Outperform | RBC Capital Markets | |
| 12.02.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 12.02.24 | AstraZeneca Overweight | Barclays Capital | |
| 09.02.24 | GSK Buy | UBS AG | |
| 09.02.24 | AstraZeneca Sell | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 4 |
| Unilever | 2 |
| Diageo | 2 |
| GSK | 2 |
| easyJet | 1 |
| Rolls-Royce | 1 |
| BAT | 1 |
| Reckitt Benckiser | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.